Market Overview:
The global measles market is segmented on the basis of type, application and region. The type segment is further divided into antibiotic, antiviral and vaccine. The application segment is further divided into hospitals, clinics and others. The regional segment is divided into North America, Latin America, Europe, Asia Pacific and Middle East & Africa. The global measles market size was valued at US$ XX million in 2016 and it is expected to grow at a CAGR of XX% during the forecast period 2018-2030. Rising incidence of measles across the globe due to increasing number of unvaccinated population coupled with rising demand for better treatment options are some major factors driving the growth of this market during the forecast period 2018-2030.
Product Definition:
A highly contagious viral disease that is spread through coughing and sneezing, causes a rash, and can lead to serious complications.
Global Measles Market Size Growth Rate by Treatment: 2016 VS 2021 VS 2027:
Global measles market size was valued at USD 1.2 billion in 2016 and is expected to grow at a CAGR of XX% over the forecast period. The rising number of vaccination programs, increasing population base, unmet medical needs in low-income countries are some major factors driving the growth of this market globally.
Antibiotic:
Antibiotics are drugs used to treat bacterial infections. The most common types of bacterial infections include pneumonia, ear infection, skin infection and urinary tract infections. Antibiotics can be administered in two ways: as a prescription drug or as an over-the-counter product.
Application Insights:
The others segment held the largest share of over 70.0% in 2019. The others application category includes travel clinics and other non-healthcare settings such as airports, railway stations, workplaces and communities. Measles elimination is primarily targeted towards travelers who are visiting or living in affected regions, resulting in a substantial demand for vaccines from this segment.
Based on the application type, the global market has been further divided into hospitals/clinics (largest share), schools/daycare centers (second largest) and others (smallest). Hospitals/clinics accounted for a larger share due to routine immunization against measles being carried out at these facilities worldwide since last few decades due to its effectiveness as compared to other settings such as clinics or airport lounges where people come together only for a limited period of time which results in low usage rates of vaccine doses among patients there i.e., less than 80%.
Regional Analysis:
Europe dominated the global market in terms of revenue share in 2017. The region is expected to continue its dominance over the forecast period due to increasing immunization rates, rising healthcare expenditure, and growing awareness about vaccines. Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to improving economic conditions and high unmet clinical needs of target population in this region. Moreover, a large number of international travelers are likely to boost demand for vaccination programs across this region during the forecast period.
Growth Factors:
- Increasing awareness about the benefits of measles vaccination among parents and healthcare professionals
- Growing number of immunization programs for measles in developing countries
- Rising demand for combination vaccines that include measles vaccine
- increasing incidence of measles outbreaks due to low vaccine coverage rates
- Technological advancements in the development of new and more effective vaccines
Scope Of The Report
Report Attributes
Report Details
Report Title
Measles Market Research Report
By Type
Global Measles Market Size Growth Rate by Treatment: 2016 VS 2021 VS 2027, Antibiotic, Antiviral, Vaccine
By Application
Hospitals, Clinics, Others
By Companies
Novartis, Abbott, Biomedical Diagnostics, Johnson & Johnson Services, Sanofi, Merck, Serum Institute Of India
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
215
Number of Tables & Figures
151
Customization Available
Yes, the report can be customized as per your need.
Global Measles Market Report Segments:
The global Measles market is segmented on the basis of:
Types
Global Measles Market Size Growth Rate by Treatment: 2016 VS 2021 VS 2027, Antibiotic, Antiviral, Vaccine
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis
- Abbott
- Biomedical Diagnostics
- Johnson & Johnson Services
- Sanofi
- Merck
- Serum Institute Of India
Highlights of The Measles Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Global Measles Market Size Growth Rate by Treatment: 2016 VS 2021 VS 2027
- Antibiotic
- Antiviral
- Vaccine
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Measles Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Measles is a highly contagious viral illness that can cause severe respiratory infection, pneumonia, and even death. It is most commonly spread through the air, but it can also be passed through contact with saliva or mucus from an infected person. Symptoms of measles include fever, cough, runny nose and red eyes. In very rare cases measles can lead to encephalitis (a serious brain infection), which may result in deafness or blindness.
Some of the major players in the measles market are Novartis, Abbott, Biomedical Diagnostics, Johnson & Johnson Services, Sanofi, Merck, Serum Institute Of India.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Measles Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Measles Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Measles Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Measles Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Measles Market Size & Forecast, 2018-2028
4.5.1 Measles Market Size and Y-o-Y Growth
4.5.2 Measles Market Absolute $ Opportunity
Chapter 5 Global Measles Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Measles Market Size Forecast by Type
5.2.1 Global Measles Market Size Growth Rate by Treatment: 2016 VS 2021 VS 2027
5.2.2 Antibiotic
5.2.3 Antiviral
5.2.4 Vaccine
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Measles Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Measles Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Measles Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Measles Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Measles Analysis and Forecast
9.1 Introduction
9.2 North America Measles Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Measles Market Size Forecast by Type
9.6.1 Global Measles Market Size Growth Rate by Treatment: 2016 VS 2021 VS 2027
9.6.2 Antibiotic
9.6.3 Antiviral
9.6.4 Vaccine
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Measles Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Measles Analysis and Forecast
10.1 Introduction
10.2 Europe Measles Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Measles Market Size Forecast by Type
10.6.1 Global Measles Market Size Growth Rate by Treatment: 2016 VS 2021 VS 2027
10.6.2 Antibiotic
10.6.3 Antiviral
10.6.4 Vaccine
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Measles Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Measles Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Measles Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Measles Market Size Forecast by Type
11.6.1 Global Measles Market Size Growth Rate by Treatment: 2016 VS 2021 VS 2027
11.6.2 Antibiotic
11.6.3 Antiviral
11.6.4 Vaccine
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Measles Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Measles Analysis and Forecast
12.1 Introduction
12.2 Latin America Measles Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Measles Market Size Forecast by Type
12.6.1 Global Measles Market Size Growth Rate by Treatment: 2016 VS 2021 VS 2027
12.6.2 Antibiotic
12.6.3 Antiviral
12.6.4 Vaccine
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Measles Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Measles Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Measles Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Measles Market Size Forecast by Type
13.6.1 Global Measles Market Size Growth Rate by Treatment: 2016 VS 2021 VS 2027
13.6.2 Antibiotic
13.6.3 Antiviral
13.6.4 Vaccine
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Measles Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Measles Market: Competitive Dashboard
14.2 Global Measles Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novartis
14.3.2 Abbott
14.3.3 Biomedical Diagnostics
14.3.4 Johnson & Johnson Services
14.3.5 Sanofi
14.3.6 Merck
14.3.7 Serum Institute Of India
